Luxturna gene therapy

Luxturna gene therapy

Credit: OHSU News

Surgeons Andreas Lauer, M.D., (left) and Steven Bailey, M.D., (at scope) operate on Caspian Soto, 4, one of the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)

Download Photo (8.1 MB)

Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X